ID

11732

Descrição

The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI).

Palavras-chave

Versões (2)
  1. 28/07/2015 28/07/2015 -
  2. 21/11/2015 21/11/2015 -
Transferido a

28 de julho de 2015

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0 Legacy
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Criteria: Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

Inglês

Eligibility criteria

1 Formulários  
  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Descrição

Inclusion Criteria

Provision of signed informed consent
Descrição

Provision of signed informed consent

Tipo de dados

boolean

Alias
UMLS CUI-1
C0021430
Index event of ST segment elevation ACS
Descrição

Index event of non-ST or ST segment elevation ACS

Tipo de dados

boolean

Alias
UMLS CUI-1
C1536220
Index event of non-ST segment elevation ACS
Descrição

Index event of non-ST segment elevation ACS

Tipo de dados

boolean

Alias
UMLS CUI-1
C3537184
Exclusion criteria
Descrição

Exclusion criteria

Index event is an acute complication of percutaneous coronary intervention
Descrição

Index event is an acute complication of percutaneous coronary intervention

Tipo de dados

boolean

Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
Descrição

Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment

Tipo de dados

boolean

Alias
UMLS CUI-1
C1532338
Oral anticoagulation therapy that cannot be stopped
Descrição

Oral anticoagulation therapy that cannot be stopped

Tipo de dados

boolean

Alias
UMLS CUI-1
C0003281
The conditions associated with increased risk of bradycardiac events
Descrição

The conditions associated with increased risk of bradycardiac events

Tipo de dados

boolean

Alias
UMLS CUI-1
C0428977
Voltar ao início da página

Similar models

Eligibility criteria

1 Formulários
  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Inclusion Criteria
Informed consent
Item
Provision of signed informed consent
boolean
C0021430 (UMLS CUI-1)
STEMI
Item
Index event of ST segment elevation ACS
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
Index event of non-ST segment elevation ACS
boolean
C3537184 (UMLS CUI-1)
Item Group
Exclusion criteria
PCI complication
Item
Index event is an acute complication of percutaneous coronary intervention
boolean
PCI
Item
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
boolean
C1532338 (UMLS CUI-1)
anticoagulation therapy
Item
Oral anticoagulation therapy that cannot be stopped
boolean
C0003281 (UMLS CUI-1)
Bradycardia
Item
The conditions associated with increased risk of bradycardiac events
boolean
C0428977 (UMLS CUI-1)
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial